CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Mepilex +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00742183
NCT00742183N/ACompleted
CompareCT.gov

An Open, Parallel, Randomized, Comparative, Multi-centre Investigation in US Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene® in the Treatment of Partial Thickness Burns.

Molnlycke Health Care AB·interventional·Posted Aug 27, 2008·Updated Dec 8, 2017

In Brief

A clinical study evaluating Mepilex and Silvadene for Second Degree Burn. Completed, enrolled 100 participants across 10 sites.

Detailed Summary

The primary objective is to compare the incremental costs (direct and indirect) and benefits (healing outcomes, quality of life) of using foam silver dressing (Mepilex® Ag) to a Silver sulfadiazine 1% cream (Silvadene®) from the perspective of the health care provider. The secondary objectives are to investigate the safety, the tolerance and the performance on burn status including pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSecond Degree Burn
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 27, 2008
Enrollment StartAug 1, 2008
Primary CompletionOct 1, 2009
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 17.8 years ago

Interventions

Mepilexdevice

Mepilex Ag - dressing changes every 5-7 days, more frequently if needed

Silvadenedevice

Silvadene - dressing changes every day, more frequently if needed